OTC · Healthcare

Glass House Brands Inc. (GLAS)

As-reported financials and recent SEC filings for Glass House Brands Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$182.0M

Net income

$-29.7M

Net margin

-16.3%

Diluted EPS

$-0.55

ROE

-40.1%

P/E (TTM)

—

Market cap

—

Debt / equity

0.9×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$182.0M	$200.9M	$160.8M	$84.9M	$63.2M
Gross profit	$77.0M	$97.4M	$81.0M	$20.7M	$15.8M
Operating income	$-16.5M	$5.7M	$-49.5M	$-56.4M	$-36.2M
Net income	$-29.7M	$519,000	$-98.3M	$-32.9M	$-43.1M
Diluted EPS	$-0.55	$-0.21	$-1.62	$-0.83	$-1.11

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-A12B2026-06-26

CERT2026-06-26

6-K2026-06-18

6-K2026-06-17

42026-06-04

1442026-06-04

42026-05-26

42026-05-20

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on GLAS

Search Glass House Brands Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.